Increased HGF and c-Met in muscle tissues of polymyositis and dermatomyositis patients: Beneficial roles of HGF in muscle regeneration

Clinical Immunology

Volumn 136, Issue 3, 2010, Pages 387-399

  Sugiura, Tomoko ^a   Kawaguchi, Yasushi ^a   Soejima, Makoto ^a   Katsumata, Yasuhiro ^a   Gono, Takahisa ^a   Baba, Sayumi ^a   Kawamoto, Manabu ^a   Murakawa, Yohko ^b   Yamanaka, Hisashi ^a   Hara, Masako ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Alpha smooth muscle actin ( SMA); Connective tissue growth factor (CTGF); Dexamethasone; Hepatocyte growth factor (HGF); Muscle cell; Polymyositis dermatomyositis (PM DM); Transforming growth factor beta (TGF )

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; DEXAMETHASONE; INTERLEUKIN 1ALPHA; LYMPHOTOXIN; MYOD PROTEIN; MYOGENIC FACTOR 5; PROCOLLAGEN C PROTEINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; ENZYME SYNTHESIS; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MONONUCLEAR CELL; MUSCLE CELL; MUSCLE REGENERATION; MUSCLE TISSUE; MYOBLAST; MYOFIBROSIS; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 77955273483     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.04.015     Document Type: Article

References (53)

1. Bartoccioni E., Gallucci S., Scuderi F., Ricci E., Servidei S., Broccolini A., Tonali P. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin. Exp. Immunol. 1994, 95:166-172.
2. Tews D.S., Goebel H.H. Expression of cell adhesion molecules in inflammatory myopathies. J. Neuroimmunol. 1995, 59:185-194.
3. Sugiura T., Kawaguchi Y., Harigai M., Takagi K., Ohta S., Fukasawa C., Hara M., Kamatani N. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production. J. Immunol. 2000, 164:6593-6600.
4. Schmidt J., Rakocevic G., Raju R., Dalakas M.C. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. Brain 2004, 127:1182-1190.
5. Katsumata Y., Harigai M., Sugiura T., Kawamoto M., Kawaguchi Y., Matsumoto Y., Kohyama K., Soejima M., Kamatani N., Hara M. Attenuation of experimental autoimmune myositis by blocking ICOS-ICOS ligand interaction. J. Immunol. 2007, 179:3772-3779.
6. Sugiura T., Harigai M., Kawaguchi Y., Takagi K., Fukasawa C., Ohsako-Higami S., Ohta S., Tanaka M., Hara M., Kamatani N. Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. Int. Immunol. 2002, 14:917-924.
7. Goebels N., Michaelis D., Engelhardt M., Huber S., Bender A., Pongratz D., Johnson M.A., Wekerle H., Tschopp J., Jenne D., Hohlfeld R. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 1996, 97:2905-2910.
8. Emslie-Smith A.M., Engel A.G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann. Neurol. 1990, 27:343-356.
9. Dalakas M.C., Illa I., Dambrosia J.M., Soueidan S.A., Stein D.P., Otero C., Dinsmore S.T., McCrosky S. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N. Engl. J. Med. 1993, 329:1993-2000.
10. Prasad M.L., Sarkar C., Roy S., Bagchi U., Singh R.R., Singh Y.N., Sharma S., Malaviya A.N. Idiopathic inflammatory myopathy: clinicopathological observations in the Indian population. Br. J. Rheumatol. 1992, 31:835-839.
11. Raju R., Dalakas M.C. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 2005, 128:1887-1896.
12. Lundberg I., Nennesmo I., Hedfors E. A clinical, serological, and histopathological study of myositis patients with and without anti-RNP antibodies. Semin. Arthritis Rheum. 1992, 22:127-138.
13. Nyberg P., Wikman A.L., Nennesmo I., Lundberg I. Increased expression of interleukin 1alpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J. Rheumatol. 2000, 27:940-948.
14. Fernandez-Sola J., Cusso R., Picado C., Vernet M., Grau J.M., Urbano-Marquez A. Patients with chronic glucocorticoid treatment develop changes in muscle glycogen metabolism. J. Neurol. Sci. 1993, 117:103-106.
15. Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:6489-6493.
16. Miyazawa K., Shimomura T., Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J. Biol. Chem. 1996, 271:3615-3618.
17. Bussolino F., Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P.M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 1992, 119:629-641.
18. Balkovetz D.F., Lipschutz J.H. Hepatocyte growth factor and the kidney: it is not just for the liver. Int. Rev. Cytol. 1999, 186:225-260.
19. Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K., Park M., Chan A., Aaronson S., Vande Woude G.F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol. 1992, 12:5152-5158.
20. Ueki T., Kaneda Y., Tsutsui H., Nakanishi K., Sawa Y., Morishita R., Matsumoto K., Nakamura T., Takahashi H., Okamoto E., Fujimoto J. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat. Med. 1999, 5:226-230.
21. Yaekashiwa M., Nakayama S., Ohnuma K., Sakai T., Abe T., Satoh K., Matsumoto K., Nakamura T., Takahashi T., Nukiwa T. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am. J. Respir. Crit. Care Med. 1997, 156:1937-1944.
22. Okunishi K., Dohi M., Fujio K., Nakagome K., Tabata Y., Okasora T., Seki M., Shibuya M., Imamura M., Harada H., Tanaka R., Yamamoto K. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J. Immunol. 2007, 179:5504-5513.
23. Kuroiwa T., Kakishita E., Hamano T., Kataoka Y., Seto Y., Iwata N., Kaneda Y., Matsumoto K., Nakamura T., Ueki T., Fujimoto J., Iwasaki T. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J. Clin. Invest. 2001, 107:1365-1373.
24. Okunishi K., Dohi M., Nakagome K., Tanaka R., Mizuno S., Matsumoto K., Miyazaki J., Nakamura T., Yamamoto K. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 2005, 175:4745-4753.
25. Gong R., Rifai A., Tolbert E.M., Biswas P., Centracchio J.N., Dworkin L.D. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. J. Am. Soc. Nephrol. 2004, 15:2868-2881.
26. Allen R.E., Sheehan S.M., Taylor R.G., Kendall T.L., Rice G.M. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J. Cell. Physiol. 1995, 165:307-312.
27. Sheehan S.M., Tatsumi R., Temm-Grove C.J., Allen R.E. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve 2000, 23:239-245.
28. Tatsumi R., Hattori A., Ikeuchi Y., Anderson J.E., Allen R.E. Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol. Biol. Cell 2002, 13:2909-2918.
29. Anastasi S., Giordano S., Sthandier O., Gambarotta G., Maione R., Comoglio P., Amati P. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J. Cell Biol. 1997, 137:1057-1068.
30. Miyazawa K., Kitamura A., Kitamura N. Structural organization and the transcription initiation site of the human hepatocyte growth factor gene. Biochemistry 1991, 30:9170-9176.
31. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 1975, 292:344-347.
32. Parr C., Jiang W.G. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int. J. Oncol. 2001, 19:857-863.
33. Maier J., Mariotti M., Comoglio P.M., Soria M.R. Interleukin 1 induces an autocrine loop hepatocyte growth factor/c-Met in murine Kaposi-like spindle cells. Oncogene 1996, 13:1009-1015.
34. Kawaguchi Y., Harigai M., Hara M., Fukasawa C., Takagi K., Tanaka M., Tanaka E., Nishimagi E., Kamatani N. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis. J. Rheumatol. 2002, 29:1877-1883.
35. Nagahori T., Dohi M., Matsumoto K., Saitoh K., Honda Z.I., Nakamura T., Yamamoto K. Interferon-gamma upregulates the c-Met/hepatocyte growth factor receptor expression in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 1999, 21:490-497.
36. Tamura M., Arakaki N., Tsubouchi H., Takada H., Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J. Biol. Chem. 1993, 268:8140-8145.
37. Crisostomo P.R., Wang Y., Markel T.A., Wang M., Lahm T., Meldrum D.R. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am. J. Physiol. Cell Physiol. 2008, 294:C675-C682.
38. Wang M., Crisostomo P.R., Herring C., Meldrum K.K., Meldrum D.R. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R880-R884.
39. Gohda E., Takebe T., Sotani T., Nakamura S., Minowada J., Yamamoto I. Induction of hepatocyte growth factor/scatter factor by interferon-gamma in human leukemia cells. J. Cell. Physiol. 1998, 174:107-114.
40. Takami Y., Motoki T., Yamamoto I., Gohda E. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma. Biochem. Biophys. Res. Commun. 2005, 327:212-217.
41. Confalonieri P., Bernasconi P., Cornelio F., Mantegazza R. Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J. Neuropathol. Exp. Neurol. 1997, 56:479-484.
42. Amemiya K., Semino-Mora C., Granger R.P., Dalakas M.C. Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin. Clin. Immunol. 2000, 94:99-104.
43. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 1994, 331:1286-1292.
44. Matsumoto K., Tajima H., Okazaki H., Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids. J. Biol. Chem. 1992, 267:24917-24920.
45. Vial C., Zuniga L.M., Cabello-Verrugio C., Canon P., Fadic R., Brandan E. Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation. J. Cell. Physiol. 2008, 215:410-421.
46. Sabourin L.A., Rudnicki M.A. The molecular regulation of myogenesis. Clin. Genet. 2000, 57:16-25.
47. Tatsumi R., Anderson J.E., Nevoret C.J., Halevy O., Allen R.E. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev. Biol. 1998, 194:114-128.
48. Maeda N., Kanda F., Okuda S., Ishihara H., Chihara K. Transforming growth factor-beta enhances connective tissue growth factor expression in L6 rat skeletal myotubes. Neuromuscul. Disord. 2005, 15:790-793.
49. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
50. Vandekerckhove J., Bugaisky G., Buckingham M. Simultaneous expression of skeletal muscle and heart actin proteins in various striated muscle tissues and cells. A quantitative determination of the two actin isoforms. J. Biol. Chem. 1986, 261:1838-1843.
51. Babai F., Musevi-Aghdam J., Schurch W., Royal A., Gabbiani G. Coexpression of alpha-sarcomeric actin, alpha-smooth muscle actin and desmin during myogenesis in rat and mouse embryos I. Skeletal muscle. Differentiation 1990, 44:132-142.
52. Li Y., Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am. J. Pathol. 2002, 161:895-907.
53. Dammeier J., Beer H.D., Brauchle M., Werner S. Dexamethasone is a novel potent inducer of connective tissue growth factor expression. Implications for glucocorticoid therapy. J. Biol. Chem. 1998, 273:18185-18190.